Huntington Disease: The Complexities of Making and Disclosing a Clinical Diagnosis After Premanifest Genetic Testing

about

Genetic Risk of Alzheimer's Disease: Three Wishes Now That the Genie is Out of the Bottle

P2860

Q57068307-952DF7B6-C44A-4D25-8FE6-EDA3D2856FC2

P2860

Huntington Disease: The Complexities of Making and Disclosing a Clinical Diagnosis After Premanifest Genetic Testing

Item

http://www.wikidata.org/entity/Q42288611

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Huntington Disease: The Comple ...... er Premanifest Genetic Testing

@en

Huntington Disease: The Comple ...... er Premanifest Genetic Testing

@nl

type

Item

label

Huntington Disease: The Comple ...... er Premanifest Genetic Testing

@en

Huntington Disease: The Comple ...... er Premanifest Genetic Testing

@nl

prefLabel

Huntington Disease: The Comple ...... er Premanifest Genetic Testing

@en

Huntington Disease: The Comple ...... er Premanifest Genetic Testing

@nl

P1476

Huntington Disease: The Comple ...... er Premanifest Genetic Testing

@en

P2093

Clement T Loy

http://www.w3.org/2001/XMLSchema#string

Elizabeth A McCusker

http://www.w3.org/2001/XMLSchema#string

P2860

Determinants of functional disability in Huntington's disease: role of cognitive and motor dysfunction

Characterization of a large group of individuals with huntington disease and their relatives enrolled in the COHORT study.

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials.

Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.

Prediction of manifest Huntington's disease with clinical and imaging measures: a prospective observational study

Huntington disease: natural history, biomarkers and prospects for therapeutics.

Longitudinal Psychiatric Symptoms in Prodromal Huntington's Disease: A Decade of Data.

To tell or not to tell: on disclosing the diagnosis of dementia.

CAG-repeat length and the age of onset in Huntington disease (HD): a review and validation study of statistical approaches.

P304

467

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7916/D8PK0TDD

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28975045

http://www.w3.org/2001/XMLSchema#string

P921

Huntington disease

P932

5623754

http://www.w3.org/2001/XMLSchema#string

Huntington Disease: The Complexities of Making and Disclosing a Clinical Diagnosis After Premanifest Genetic Testing

about

P2860

P2860

Huntington Disease: The Complexities of Making and Disclosing a Clinical Diagnosis After Premanifest Genetic Testing

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P921

P932